Travere Therapeutics (TVTX) has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration seeking priority review ...

Travere Therapeutics' Filspari boosts revenue with FDA approval, but heavy losses and competitive threats raise concerns for ...

FSG's Multi-Club Plans and What They Mean for Liverpool written on March 13, 2025 by Jackson Lee. This article is about ...

The company aims to complete the sNDA submission by the first quarter of 2025, which could potentially lead to Filspari entering the FSGS market by late 2025. In addition, Canaccord Genuity ...

Fans Beaten Down to Expect No Purchases Unless Players Sold” written on March 14, 2025 by Jackson Lee. This article is about ...

Long-term abuse of anabolic steroids can lead to focal segmental glomerulosclerosis (FSGS), according to a recent study. Although anabolic steroid abuse is known to have adverse effects on the ...

Under the deal, FUSO has been granted exclusive rights to commercialise DMX-200 for FSGS in Japan. Dimerix may become ...

Sustainability Summary is not assigned to this investment. We sell different types of products and services to both investment professionals and individual investors. These products and services ...

Liverpool’s owners are now weighing up four of those clubs for purchase, having been deemed the most suitable to join a new ...

A new study published in the journal of BMC Nephrology revealed rituximab to be an effective and safe steroid sparing medication in individuals with steroid dependent (SD)/frequent relapsing ...

FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...